| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cosmos Health Inc. (NASDAQ:COSM) shares surged 30.98% to $1.15 after announcing a $300 million financing facility to launch an Ethereum (CRYPTO: ETH) treasury strategy, joining a growing trend of corporations adopting digital asset reserves.
The healthcare group secured the senior secured convertible notes facility from a U.S. institutional investor. Under the agreement, 72.5% of net proceeds must go toward building Ethereum reserves, with remaining funds supporting working capital and growth initiatives.
BitGo Trust Company will custody and stake the ETH assets through institutional infrastructure. CEO Greg Siokas called the move “a strategic milestone” providing shareholders direct ETH exposure.
The financing follows explosive growth in corporate Ethereum adoption. BitMine Immersion Technologies Inc. (NASDAQ:BMNR) now holds 833,133 ETH tokens worth $3 billion, making it the world’s largest Ethereum treasury holder, according to Fundstrat data.
Standard Chartered research shows Ethereum treasury companies have matched ETF buying since June 1, each acquiring approximately 1.6% of total ETH circulation.
Fundstrat’s Tom Lee positions Ethereum treasury strategies as among the “biggest macro trends for the next 10-15 years.” Lee sees ETH experiencing its “2017 Bitcoin (CRYPTO: BTC) moment” with institutional adoption accelerating.
Major Wall Street institutions like JPMorgan Chase & Co. (NYSE:JPM) built stablecoins on Ethereum, while Robinhood Markets Inc. (NASDAQ:HOOD) develops tokenization infrastructure on the platform.
Cosmos Health plans to use the remaining facility proceeds for U.S. manufacturing expansion, R&D innovation, and commercial initiatives. The company operates through subsidiaries manufacturing pharmaceuticals and nutraceuticals across Europe, Greece, and the UK.
The diversified healthcare group owns proprietary brands, including Sky Premium Life and Mediterranation, with recent telehealth expansion through the ZipDoctor acquisition.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Zakharchuk on Shutterstock.com
